The Oncology Institute, Inc.
TOI
$2.96
-$0.14-4.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.95% | 13.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.95% | 13.99% | |||
| Cost of Revenue | 1.32% | 15.00% | |||
| Gross Profit | 20.32% | 8.11% | |||
| SG&A Expenses | 11.05% | -6.15% | |||
| Depreciation & Amortization | -5.28% | -4.54% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.94% | 10.38% | |||
| Operating Income | 14.24% | 28.16% | |||
| Income Before Tax | 54.51% | 3.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.51% | 2.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.51% | 2.97% | |||
| EBIT | 14.24% | 28.16% | |||
| EBITDA | 16.68% | 32.69% | |||
| EPS Basic | 55.20% | 5.86% | |||
| Normalized Basic EPS | 56.24% | 7.92% | |||
| EPS Diluted | 54.42% | 5.86% | |||
| Normalized Diluted EPS | 56.24% | 7.92% | |||
| Average Basic Shares Outstanding | 4.09% | 4.58% | |||
| Average Diluted Shares Outstanding | 4.09% | 4.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||